Two Sigma Investments
MRVI icon

Two Sigma Investments’s Maravai LifeSciences MRVI Stock Holding History

Two Sigma Investments’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
2,255,820
+675,980
+43% +$2.92M 0.01% 1274
2026
Q1 		$4.47M Buy
1,579,840
+734,432
+87% +$2.49M ﹤0.01% 2071
2025
Q4 		$2.75M Sell
845,408
-326,840
-28% -$1.1M ﹤0.01% 2197
2025
Q3 		$3.36M Sell
1,172,248
-160,513
-12% -$410K 0.01% 1765
2025
Q2 		$3.21M Sell
1,332,761
-101,710
-7% -$214K 0.01% 1522
2025
Q1 		$3.17M Buy
1,434,471
+1,325,052
+1,211% +$5.24M 0.01% 1410
2024
Q4 		$596K Sell
109,419
-163,923
-60% -$1.05M ﹤0.01% 2455
2024
Q3 		$2.27M Buy
273,342
+19,142
+8% +$165K 0.01% 1593
2024
Q2 		$1.82M Sell
254,200
-239,922
-49% -$2.07M ﹤0.01% 1619
2024
Q1 		$4.28M Buy
494,122
+347,226
+236% +$2.35M 0.01% 1056
2023
Q4 		$962K Sell
146,896
-398,373
-73% -$2.57M ﹤0.01% 2107
2023
Q3 		$5.45M Sell
545,269
-1,817,449
-77% -$20M 0.01% 856
2023
Q2 		$29.4M Buy
2,362,718
+560,509
+31% +$7.57M 0.07% 317
2023
Q1 		$25.2M Buy
1,802,209
+245,742
+16% +$3.53M 0.07% 312
2022
Q4 		$22.3M Buy
1,556,467
+1,018,173
+189% +$16M 0.07% 324
2022
Q3 		$13.7M Sell
538,294
-83,978
-13% -$2.11M 0.05% 404
2022
Q2 		$17.7M Sell
622,272
-10,649
-2% -$337K 0.06% 355
2022
Q1 		$22.3M Buy
632,921
+226,041
+56% +$7.58M 0.07% 359
2021
Q4 		$17M Buy
406,880
+377,172
+1,270% +$15.3M 0.04% 545
2021
Q3 		$1.46M Sell
29,708
-409,368
-93% -$20M ﹤0.01% 2269
2021
Q2 		$18.3M Buy
439,076
+216,870
+98% +$8.41M 0.04% 523
2021
Q1 		$7.92M Sell
222,206
-65,992
-23% -$2.19M 0.02% 814
2020
Q4 		$8.08M Buy
+288,198
New +$8.03M 0.02% 680

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Two Sigma Investments's MRVI Position: Q2 2026 in Review

Two Sigma Investments increased its Maravai LifeSciences (MRVI) stake by 43% in Q2 2026, buying an estimated $2.92M and bringing the position to 2,255,820 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #1274.

Two Sigma Investments first reported a position in MRVI in Q4 2020 and has held it in 23 quarters since. The position peaked at $29.4M in Q2 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Two Sigma Investments held 2,255,820 shares of Maravai LifeSciences worth $14.1M as of Q2 2026.
  • Two Sigma Investments bought 675,980 Maravai LifeSciences shares in Q2 2026, an estimated $2.92M.
  • Maravai LifeSciences made up 0.01% of Two Sigma Investments's portfolio in Q2 2026, its #1274 holding.
  • Two Sigma Investments first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • Two Sigma Investments's Maravai LifeSciences position peaked at $29.4M in Q2 2023.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.